Ticker Scorecard - OCUL Basics Company: Ocular Therapeutix, Inc. IPO Date: July 25, 2014 Sector: Healthcare Industry: Biotech Market Cap: $1.1B Activated in VL: True Average Daily Range Avg Daily Range: $0.27 | 3.20% Avg Daily Range (30 D): $0.15 | 1.91% Avg Daily Range (90 D): $0.22 | 2.38% Institutional Daily Volume Avg Daily Volume: .74M Avg Daily Volume (30 D): .74M Avg Daily Volume (90 D): .79M Trade Size Avg Trade Size (Sh.): 140 Avg Trade Size (Sh.) (30 D): 88 Avg Trade Size (Sh.) (90 D): 87 Institutional Trades Total Inst.Trades: 965 Avg Inst. Trade: $1.69M Avg Inst. Trade (30 D): $1.11M Avg Inst. Trade (90 D): $1.5M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.7M Avg Closing Trade (30 D): $1.11M Avg Closing Trade (90 D): $1.44M Avg Closing Volume: 183.13K     News Jan 17, 2025 @ 12:00 PM Ocular Therapeutixâ„¢ Reports Inducement Grant... Source: Ocular Therapeutix, Inc. Jun 14, 2024 @ 12:01 PM Deep Dive Into Ocular Therapeutix Stock: Analyst P... Source: Benzinga Insights Jun 13, 2024 @ 8:05 PM Ocular Therapeutixâ„¢ Highlights Exceptional A... Source: Ocular Therapeutix, Inc. Jun 5, 2024 @ 11:30 AM Ocular Therapeutix® to Host Investor Day on Jun... Source: Ocular Therapeutix, Inc. Jun 4, 2024 @ 8:05 PM Ocular Therapeutix® Reports Inducement Grants U... Source: Ocular Therapeutix, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.32 $-.22 $-.26 Diluted EPS $-1.22 $-.22 $-.26 Revenue $ 61.44M $ 15.43M $ 16.44M Gross Profit $ 55.66M $ 13.86M $ 14.93M Net Income / Loss $ -174.34M $ -36.49M $ -43.78M Operating Income / Loss $ -141.26M $ -46M $ -43.59M Cost of Revenue $ 5.78M $ 1.56M $ 1.51M Net Cash Flow $ 316.52M $ -32.47M $ -23.35M PE Ratio